SERPINA1, serpin family A member 1, 5265

N. diseases: 482; N. variants: 61
Disease: Protein-Losing Enteropathies ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0033680
Disease: Protein-Losing Enteropathies
Protein-Losing Enteropathies 		0.050 Biomarker group BEFREE Stool for alpha-1 antitrypsin was >1.2 mg/g (<0.6) which supported the diagnosis of PLE. 28263087 2018
CUI: C0033680
Disease: Protein-Losing Enteropathies
Protein-Losing Enteropathies 		0.050 Biomarker group BEFREE Future longitudinal follow-up studies should assess the ability of alpha-1-antitrypsin to provide earlier detection of protein-losing enteropathy in asymptomatic patients post Fontan. 28879464 2018
CUI: C0033680
Disease: Protein-Losing Enteropathies
Protein-Losing Enteropathies 		0.050 Biomarker group BEFREE Fecal alpha-1-antitrypsin (A1AT) clearance was measured as biomarker for PLE. 28849396 2017
CUI: C0033680
Disease: Protein-Losing Enteropathies
Protein-Losing Enteropathies 		0.050 Biomarker group BEFREE Esophagogastroduodenoscopy and stool alpha-1 antitrypsin indicated protein-losing enteropathy. 28541008 2017
CUI: C0033680
Disease: Protein-Losing Enteropathies
Protein-Losing Enteropathies 		0.050 Biomarker group BEFREE A handful of biomarkers have been integrated into adult CHD practice, such as iron studies in cyanotic heart disease and stool alpha-1 antitrypsin for diagnosis of protein losing enteropathy in the Fontan circulation. 28432659 2017